Mangaluru: Two held for stripping, robbing, blackmailing student on V-Day

Udupi, May 20: All the six fishermen were rescued from a deep-sea fishing boat, which capsized after hitting a rock near Malpe here yesterday. 

The boat was owned by Reshma Kharvi. The incident occurred while the boat was returning after fishing to Malpe harbor. 

The helmsman lost control over the boat after steering got damaged and hit the rock and damaged. 

The crew of another boat which was near to the sinking boat immediately rushed and rescued six fishermen.

Attempts to rescue the sinking boat using the yet another boat could not materialise. 

The loss is said to be about Rs 80 lakh, including Rs. 5 lakh worth items, including fish, net, and other accessories. The boat ventured from Malpe port on May 14.

Mangaluru, Jul 19: In the wake of the COVID-19 lockdown imposed till July 23, streets in the Dakshina Kannada district here bore a deserted look today (Sunday) morning.

The state government had allowed relaxation hours between 8 am to 11 am in the week-long total shutdown. However today there was no relaxation. 

All shops including those selling essential commodities were also seen closed in the district today. Besides, barricades were also seen stationed at different junctures on the road.

As per Karnataka's COVID-19 information portal, a total of 59,652 coronavirus cases have been reported in the state, including 36,631 active cases and 21,775 recoveries. So far, 1,240 people have died due to the infection in the state. 

Dakshina Kannada so far recorded 3,311 covid-19 positive cases and 75 deaths.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.